glp-1 therapies WHO Endorses GLP‑1 Therapy Obesity Care: Implications for Diabetes Providers GLP-1 Drugs & What They

Aoo Felipe , Endicrinologist who took part as guest speakers to educate us on the effects, clinical settings and benefits of L-Carnitine to our body

doi: 10.1016/j.jff.2017.02.006 97

Your body makes enzymes, but GLP-1s change how fast food moves through your system

You have undergone bariatric surgery within the past 6 months

Common maintenance approaches include staying at the dose where you stabilized (often 1.0 to 1.7 mg), reducing by one dose level from your peak (e.g., from 2.4 mg to 1.7 mg), or finding the minimum dose that prevents weight regain while minimizing side effects

10.1358/dof.2019.44.6.2927591